Transactivation of vimentin by beta-catenin in human breast cancer cells.

@article{Gilles2003TransactivationOV,
  title={Transactivation of vimentin by beta-catenin in human breast cancer cells.},
  author={Christine Gilles and Myriam Polette and M{\'e}lanie Mestdagt and B{\'e}atrice Nawrocki-Raby and Philippe Ruggeri and Philippe Birembaut and J. -M. Foidart},
  journal={Cancer research},
  year={2003},
  volume={63 10},
  pages={2658-64}
}
The cytoplasmic and nuclear redistribution of beta-catenin and the de novo expression of vimentin are frequently involved in the epithelial-to-mesenchymal transition associated with increased invasive/migratory properties of epithelial cells. Because beta-catenin can act as a coactivator of transcription through its binding to the T-cell factor (TCF)/lymphoid enhancer factor 1 transcription factor family, we have explored the possibility that beta-catenin/TCF could directly transactivate… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 101 extracted citations

HIPK2 downregulates vimentin and inhibits breast cancer cell invasion.

Cancer biology & therapy • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…